5-azacytosine has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Craddock, C | 1 |
| Jehn, U; Knüppel, W; Wilmanns, W | 1 |
1 trial(s) available for 5-azacytosine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Intensive maintenance treatment in acute myelogenous leukemia (AML): single institution experience of a multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Cytosine; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Leukemia, Myeloid, Acute; Middle Aged; Random Allocation; Vincristine | 1988 |
1 other study(ies) available for 5-azacytosine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Epigenetic manipulation of the immune response: a novel treatment strategy in hematologic malignancies.
Topics: Antigens, Neoplasm; Chromatin; CpG Islands; Cytosine; DNA Methylation; Epigenesis, Genetic; Hematologic Neoplasms; Histone Deacetylase Inhibitors; Humans; Immunity, Cellular; Leukemia, Myeloid, Acute; Methyltransferases; Myelodysplastic Syndromes; Neoplasm Proteins; Promoter Regions, Genetic | 2011 |